Back to top

Cantor Fitzgerald Sticks to Its Buy Rating for Amicus (FOLD)

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Amicus, with a price target of $21.00. Kluska cove...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amicus Therapeutics, Inc. (FOLD)